Atlas Trials

David Bond, MD

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch David Bond, MD

RecordFirmDate
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma (NCT05821088)David Bond, MD2023-06-29
Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma (NCT03892044)David Bond, MD2019-11-05
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma (NCT03749018)David Bond, MD2019-01-02
Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma (NCT03015896)David Bond, MD2017-02-14

Track David Bond, MD automatically

Every clearance here is in the API, with alerts when new ones post.